Phytochemical Constituents from <i>Globimetula oreophila</i> as Plasmepsin I and II Inhibitors in Antimalarial Drug Discovery: An In Silico Approach

Malaria remains a critical global health challenge, particularly affecting Sub-Saharan Africa. Plasmepsins, vital in hydrolyzing peptide bonds within proteins, present promising targets for antimalarial drugs. Plasmepsins I and II, key aspartic proteases, are crucial in various parasite processes. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Dauda Garba, Bila Hassan Ali, Bashar Bawa, Abdullahi Maryam, Hamza Asmau Nasiru, Yahaya Mohammed Sani, Muhammad Garba Magaji, Musa Isma’il Abdullahi, Aliyu Muhammad Musa, Hassan Halimatu Sadiya
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Chemistry Proceedings
Subjects:
Online Access:https://www.mdpi.com/2673-4583/16/1/42
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malaria remains a critical global health challenge, particularly affecting Sub-Saharan Africa. Plasmepsins, vital in hydrolyzing peptide bonds within proteins, present promising targets for antimalarial drugs. Plasmepsins I and II, key aspartic proteases, are crucial in various parasite processes. This study investigates the inhibitory properties of quercetin, quercetrin, dihydrostilbene, 4′-methoxy-isoliquiritigenin, and stigmasterol from <i>Globimetula oreophila</i> on plasmepsins through in silico techniques, including ADME predictions and molecular docking. Results reveal strong interactions of these compounds with active site residues, with quercetrin and stigmasterol displaying notable binding affinities. These findings suggest the potential of <i>G. oreophila</i> metabolites as potent plasmepsin inhibitors, offering prospects for malaria treatment and prevention.
ISSN:2673-4583